BioAge Labs Target Price

Where could BIOA trade next? Consensus target price: $27.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.49

Average Target Price

$27.33

221.9% upside

3 analysts in the last 4 months

High: $36 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-31	Roth CapitalAdam Walsh	$25	194.5% upside
2026-07-31	Jefferies	$21	147.3% upside
2026-05-27	Roth CapitalAdam Walsh	$36	324% upside
2026-05-13	BTIG	$40	371.1% upside
2026-03-27	Needham	$50	488.9% upside
2026-02-18	JefferiesRoger Song	$62	630.3% upside
2026-02-04	Morgan Stanley	$23	170.9% upside
2025-12-05	Morgan Stanley	$12	41.3% upside
2025-03-07	Morgan Stanley	$5	41.1% downside
2024-12-09	JefferiesRoger Song	$7	17.6% downside
2024-10-21	CitigroupSamantha Semenkow	$45	430% upside
2024-10-21	JefferiesRoger Song	$42	394.7% upside
2024-10-21	Morgan StanleyJeffrey Hung	$40	371.1% upside

BioAge Labs (BIOA) FAQ

BioAge Labs posts a target price of $27. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $27 for BIOA means covering analysts, on average, see the stock 221.9% upside of $8.49 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for BIOA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioAge Labs's other metric pages and overview cover the third.